Scholars Central

Conference abstractPublished 30 Aug 2013

Candida bloodstream infections: Species distribution and antifungal resistance in general medicine wards and in intensive care units

Authors: Maria Teresa Mascellino

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Candidaemia is increasing Worldwide but over the last years it is not mainly found in the ICUs (Intensive Care Units) (as it occurred in the past) but found in General Medicine wards. A total of 542 isolates of Candida spp . were obtained in both ICUs (268; 49.4%) and in General Medicine (274; 50.5%) in Policlinico Umberto I Sapienza University of Rome through years 2009-2012. The frequency of ICU-associated candidaemia decreased over the last 4-year of study period (Incidence 25% in 2009, 20.8% in 2010, 20.2% in 2011 and 19.2% in 2012). C. albicans was detected in 42% of cases and C. non-albicans in 58%. C. parapsilosis showed a strong raise principally in 2011 as well as C. glabrata and C. tropicalis . C. krusei detection was very low (about 2%) resulting the most uncommon species. Approximately 97% of isolates both in ICU and non-ICU settings were caused by only five species ( C. albicans, C. parapsilosis, C. glabrata, C. tropicalis and C. krusei ). Comparing the isolation of frequency of different species by ICU versus non ICU BSIs (bloodstream infections), only minor differences was found (not statistically significant). C. albicans and C. parapsilosis were more common among ICU infections whereas C. albicans and C. glabrata were more common in non ICU BSIs. The Candida isolates resistance to azoles and echinocandins resulted to be very unusual in both ICU and in non ICU settings. Fluconazole resistance was detected in 3% of ICU isolates and 2.4% of non-ICU isolates. A slight increase of fluconazole resistance in high-risk wards is probably due to the greater use of fluconazole as prophylactic tool in these areas. C. glabrata and C. krusei showed the highest rate of resistance to fluconazole. Global mortality rate of candidaemia resulted to be approximately of 43%. In conclusion, we can say that the trend towards a decrease in ICU-associated candidaemia is consistent. In fact invasive candidiasis can no longer be considered to be just an ICU-related infections but the onset of Candida BSIs is shifting from the ICU to other hospital settings. Moreover the species distribution and the antifungal resistance profiles are very similar for isolates from both hospital locations. Any Candida isolateted from ICU exhibit no greater resistance to antifungal agents than those cultured from the non ICU setting

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical & Experimental Pathology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pathology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Maria Teresa Mascellino”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels